Zai Lab Announces The New England Journal of Medicine Publication Demonstrating Durable Clinical Activity of Repotrectinib in Patients with Advanced ROS1 Fusion-Positive NSCLC streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
SHANGHAI, China and CAMBRIDGE, Mass., Sept. 18, 2023 (GLOBE NEWSWIRE) Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the Center for Drug Evaluation (CDE) of the National
SHANGHAI, China and CAMBRIDGE, Mass., Sept. 18, 2023 Zai Lab Limited today announced that the Center for Drug Evaluation of the National Medical Products Administration granted Breakthrough.
SHANGHAI, China and CAMBRIDGE, Mass., May 25, 2023 Zai Lab Limited today announced that members of the company’s senior management team will participate in the following investor. | May 25, 2023